U.S. Inflammatory Bowel Disease Treatment Market Is Expected To Reach $ 15.70 Billion By 2030
San Francisco, 13 Novembers 2025: The Report U.S. Inflammatory Bowel Disease Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts The U.S. inflammatory bowel disease treatment market size is anticipated to reach USD 15.70 billion by 2030 and is projected to grow at a CAGR of 2.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of ulcerative colitis and Crohn’s disease across the U.S. is anticipated to drive market growth in the forecast period. A combination of genetic predisposition, immune system dysfunction, environmental factors, gut microbiota imbalance, and lifestyle factors likely influence the development of inflammatory bowel disease (IBD). According to an article published in 2023, inflammatory bowel disease is a relatively...